4593 Healios KK
- 166
- +7+4.40%
Healios KK News
Healios KK: Extraordinary Report
Healios KK: Confirmation letter
Healios KK: Quarterly Report - 14th quarter 1st quarter (2024/01/01 - 2024/03/31)
Healios KK: Financial results for the 1st quarter of 2024
Healios KK: Presentation of financial results for the 1st quarter of the fiscal year ending 2024/12
Healios KK: Notice regarding the recording of financial income and financial expenses
Healios KK: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)
Healios KK: Corporate Governance Report 2024/04/12
Healios KK: Joint Research Agreement with AND medical to Utilize Healios Technology and Culture Supernatant
Healios KK: Announcement of the conclusion of a joint research agreement with AND Medical to utilize culture supernatants
Healios KK: Healios Acquires Substantially All of the Assets of Athersys, Inc. Free and Clear of Liabilities, Becomes Sole Owner of MultiStem
Healios KK: Acquisition of all substantial assets of Assassis' - acquisition of sole rights to the somatic stem cell regenerative medicine product MultiStem Cell
Healios KK: Confirmation letter
Helios: Financial Report - Term 13 (2023/01/01 - 2023/12/31)
Helios: Internal Control Report - Term 13 (2023/01/01 - 2023/12/31)
Helios: Extraordinary Report
Healios KK: Corporate Governance Report 2024/03/28
Healios KK: Announcement of the presentation of research results on enK cell hepatocellular carcinoma at the 23rd Annual Meeting of the Japanese Society for Regenerative Medicine
Healios KK: Matters relating to business plans and growth potential
Healios KK: Presentation of the research results of Healios’ eNK cells on mesothelioma at AACR Annual Meeting 2024
Analysis
Price Target
No Data
